AxonDAO Launches A+Voice: Transforming Health Monitoring with Vocal Biomarkers

AxonDAO (Axon DAO LLC, Wyoming) is excited to announce the launch of A+Voice, a pioneering research platform designed to monitor vocal biomarkers. This groundbreaking tool offers effective early detection and ongoing assessment for conditions such as Alzheimer’s, Parkinson’s, dementia, post-traumatic stress disorder (PTSD), and Huntington’s Disease.

Monitoring Vocal Biomarkers for Better Health

A+Voice leverages vocal biomarkers to evaluate fatigue and energy levels, which could revolutionize safety monitoring across various professions, including operators of commercial trucks, cars, and heavy machinery. AxonDAO aims to further refine their models to detect biomarkers indicating changes in anxiety, stress, and mood.

Empowering Research with Advanced Technology

By integrating decentralized ledger technology, zero-knowledge security, and other advanced technologies, AxonDAO empowers research participants to access, own, and control their health data. This approach facilitates large-scale research studies, surpassing traditional methods used by academia and industry.

Introducing A+Voice

A+Voice is AxonDAO’s innovative biometric AI voice collection and analysis software. The platform uses a reward system to collect high-quality, consistent voice data, which is then processed through a quality assessment and analytical engine. Utilizing blockchain technology, A+Voice timestamps, anonymizes, and processes data into patterned AI processes while maintaining stringent HIPAA and ISO 27001 compliance standards for secure data handling.

Strategic Collaborations and Milestones

AxonDAO’s dedication to excellence is highlighted by its recent approval for NVIDIA’s Inception Program on October 27, 2023. In March, the AxonDAO team presented its vision at NVIDIA’s GTC event in San Jose, California. Key strategic partnerships have played a crucial role in the launch of A+Voice:

  • NVIDIA: Facilitating the scaling of A+Voice and related products through cutting-edge GPU processors.
  • 639 Solar: Hosting AxonDAO’s DeSci Research Toolkit and Computational Engine in one of the world’s largest solar-powered data centers.
  • DataLake: Ensuring industry standards in consent management, including user rights to revoke personal data access.

AxonDAO’s Vision and Market Potential

AxonDAO is committed to advancing human relationships and scientific research through biometric data. The personal data market, valued at $1.61 trillion, is projected to grow to $17.06 trillion by 2029 with the integration of high-quality biometric data.

Join the Discussion on Mario’s Nawfal Roundtable X Account

AxonDAO will be featured on Mario’s Roundtable X account this Thursday, June 13th, at 12:00 PM EST. Join the session to learn more about AxonDAO’s groundbreaking work and its vision for the future of decentralized science.


Disclaimer: Not Investment Advice

it’s crucial to understand that the information provided here is not to be construed as investment advice. The crypto market is dynamic and highly speculative, and decisions should be made based on thorough personal research and consideration of individual risk tolerance. Always consult with financial professionals and conduct your own due diligence before making any investment decisions. The intention of this exploration is to present insights and trends, not to provide specific investment recommendations.

Follow Us

Top Selling Multipurpose WP Theme


Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!


Crypto feed news

Our team of crypto enthusiasts and market mavens is on a mission to deliver the latest, juiciest, and most insightful updates from the ever-evolving world of cryptocurrencies.

@CryptoFeedNews 2023 All Right Reserved. Designed and Developed by TheDevThingz

Skip to content